CTLA4 and metastatic melanoma: To explore whether the IRG risk score could predict the response to immunotherapy, we applied the IRG risk score in the Van_allen dataset, the sequencing data from metastatic melanoma treatment with cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) blockade [14].